Niacin shrinks artery plaque; Merck’s Zetia does not and may carry risks, new study finds more images FDA approves first non-hormone therapy for excessive menstrual bleeding
Lexicon Pharma says its irritable bowel syndrome drug LX1031 met study goal; shares jump
Lexicon says IBS drug met mid-stage study goal Myriad Pharma reports lower research and development costs in 1st quarter after spinoff
Product Recalls: weight loss and dietary supplements, tree stands, backpack blowers
Analysis finds reports on Pfizer epilepsy drug studies misleading; drugmaker disputes review more images FDA OKs camelina as cattle feed supplement; approval may help Montana’s biofuel crop industry
FDA approves camelina as cattle feed supplement Two universities to shun Kindle until Amazon makes e-reader accessible to blind users
Schools shun Kindle, saying blind can’t use it Teva Pharmaceutical receives FDA approval for generic version of heartburn drug Prevacid
Pfizer closing some research plants, consolidating others and cutting staff after buying Wyeth more images Lawmaker asks GAO to investigate school lunch safeguards against deadly E. coli
Lawmaker wants probe of E. coli and school lunches Recalls: Anesthetic medications
Recalls: Anesthetic medications The following recall has been announced: Salmonella outbreak victims upset by lack of prosecution in what lawyers call cut-and-dry case
Salmonella victims upset no prosecutions yet FDA panel rejects Zimmer spine repair device on questions of safety and effectiveness
FDA panel rejects Zimmer spine implant GAITHERSBURG, Md. — Federal health advisers on Wednesday rejected an implant from Zimmer Holdings saying it’s unclear how effective or safe the device would be for treating a painful spinal condition. Phase Forward board authorizes up to $40 million in share buybacks over the next year
Phase Forward authorizes up to $40M in buybacks FDA will identify riskiest drug types to help reduce medication errors, accidental overdoses
FDA launches plan to curb accidental overdoses Product recalls: cookies, hot chocolate mix, dietary supplements, pain treatment injections
Health regulators probe influence of financial payments on Zimmer spinal implant study
FDA questions role of payments in Zimmer study CDC: 2 deaths, 26 other illnesses may be linked to fresh ground beef contaminated with E. coli
CDC: Tainted ground beef may be linked to 2 deaths Merck: FDA won’t accept its application for combo cholesterol pill including Pfizer’s Lipitor
FDA won’t accept Merck’s application for new drug CDC: 2 deaths, 26 illnesses may be linked to E. coli-contaminated beef that has been recalled
CDC: Contaminated beef may be linked to 2 deaths Amylin Pharmaceuticals signs weight-loss drug deal with Takeda potentially worth over $1B more images NY company recalls 546,000 pounds of ground beef over E. coli illnesses, including death
Ground beef recalled over E. coli illnesses Human Genome Sciences, GlaxoSmithKline report positive results in 2nd lupus drug study
Human Genome reports positive data on lupus drug Schering posts boceprevir trial data, including results for patients not helped by other drugs more images FDA sends warning to P&G over ‘illegal marketing’ of Vicks products containing vitamin C
FDA warns P&G over Vicks products with vitamin C Phase Forward posts 3rd-quarter profit decline, tops Wall Street’s forecast
Phase Forward posts 3rd-quarter profit decline Human Genome Sciences reports smaller 3Q loss after completing tests of lupus drug Benlysta
FDA panel recommends approval of novel heat-based treatment for treating asthma
FDA panel backs first non-drug asthma treatment SciClone will cut 7 jobs in restructuring after canceling cancer drug trial
SciClone will cut about 40 jobs in restructuring after canceling cancer drug trial
GlaxoSmithKline third quarter profit up 11 percent; expects more gains in final quarter
FDA experts request more data on benefit of Human Genome Sciences’ anthrax drug
FDA panel wants more data on anthrax drug WASHINGTON — Federal advisers said Tuesday that more data is needed to judge the effectiveness of Human Genome Sciences’ anthrax treatment compared with existing anti-bacterial drugs. Correction: FDA drug label story
Arena Pharma reports new results on obesity drug candidate at conference, and shares advance
German drug maker Merck 3rd quarter net income falls 28 percent to $216 million
GAO finds FDA unwilling to pull drugs off the market, even when their benefits are unclear
Raging hormones: Unproven ‘bioidenticals’ for menopause contain estrogen too, experts say
FDA says Human Genome anthrax drug works in animals, questions remain about human useFDA reviews Human Genome’s anthrax medication WASHINGTON — The Food and Drug Administration says Human Genome Sciences’ ABthrax successfully treated animals exposed to anthrax, though the agency has questions about its use in humans. Swine flu swindles: Internet scams offer shampoo, germ-zapping spray, fake TamifluFDA warns: Swine flu scams lurk on the Internet Air “sterilizers.” A photon machine. Supplement pills to boost the immune system. Protective shampoos and face masks. Even fake Tamiflu. Amgen shares fall as company discloses additional FDA Prolia request, Arenesp dataAmgen shares fall after new Prolia request NEW YORK — Amgen Inc. shares fell Thursday over the likelihood that the biotechnology company’s next potential blockbuster will take longer than expected to reach its full sales potential in the market. Drugmaker Merck posts slight rise in 3Q sales, but big profit jump due to animal health saleMerck posts big profit jump, slight rise in sales TRENTON, N.J. — Drugmaker Merck & Co. on Thursday posted a bigger profit in the third quarter due to slightly higher sales and a huge gain from selling a business. Affymetrix reports smaller 3rd-quarter loss, but results miss estimates, shares tumbleAffymetrix posts smaller 3Q loss, but shares fall SANTA CLARA, Calif. — Affymetrix Inc., which makes genetic analysis technology, on Wednesday reported a narrower third-quarter loss, but the results missed Wall Street expectations, sending shares plunging in after-hours trading. Drug safety experts urge FDA to make drug safety info more accessible to patientsExperts: key drug facts often left off FDA labels WASHINGTON — Did you know that Lunesta will help you fall asleep just 15 minutes faster? Or that a higher dose of the osteoporosis drug Zometa could damage a cancer patient’s kidneys and raise their risk of death? Amgen’s 3rd-quarter profit rises 24 percent on lower costs as anemia drug sales continue dropAmgen 3Q profit jumps 24 percent on lower costs NEW YORK — Biotechnology company Amgen Inc. said Wednesday lower costs in its research and sales units boosted third-quarter profit by 24 percent, despite a continued downturn in anemia drug sales. Peregrine Pharmaceuticals says bavituximab prompts response in breast cancer patientsPeregrine drug prompts response in cancer study TUSTIN, Calif. — Peregrine Pharmaceuticals Inc. said Wednesday its drug candidate bavituximab prompted an improvement in response rates in advanced breast cancer patients during a midstage clinical trial. Bristol-Myers faces growing competition for key drugs as it reports 3Q resultsEarnings Preview: Bristol-Myers 3Q earnings report NEW YORK — Bristol-Myers Squibb Co., the world’s No. 15 drug maker by revenue, reports earnings for the third quarter on Thursday morning. The following is a summary of key developments and analyst opinion related to the period. Merck 3Q earnings report comes as it works to close its $41 billion buyout of Schering-PloughEarnings Preview: Merck to report 3Q earnings TRENTON, N.J. — Merck & Co., a Dow component and the world’s eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning. The following is a summary of key developments and analyst opinion related to the period. Heart failure patients often sent home without drugs recommended by guidelines, study saysStudy: Heart failure drug guidelines often ignored CHICAGO — Most hospitalized heart failure patients are sent home without widely recommended inexpensive pills, despite a program to get more doctors to follow treatment guidelines, a study suggests. Medco says it will run clinical trial to compare blood thinners Plavix and EffientMedco plans to compare Plavix, Effient in study NEW YORK — Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world’s second-best selling drug, with the newer Effient. Plum Organics recalls apples and carrots baby food because of possible botulism contaminationBaby food recalled, may be tainted with botulism WASHINGTON — Plum Organics of Emeryville, Calif., is recalling some of its apple and carrot portable pouch baby food because of concerns over possible botulism contamination. GlaxoSmithKline’s seasonal flu vaccine Fluarix approved for childrenGlaxo seasonal flu vaccine approved for children NEW YORK — GlaxoSmithKline PLC said Monday the Food and Drug Administration approved the seasonal flu vaccine Fluarix for children. Drugmaker Merck for first time discloses payments to doctors who give talks to colleaguesMerck starts revealing payments to doctor-speakers TRENTON, N.J. — Merck & Co. paid doctors and nurses a total of $3.7 million this summer to give talks to colleagues about the drugmaker’s products and other health topics, Merck disclosed Monday. For now, flu vaccine scarcer than expected; kids at higher risk as disease strikes US earlyHitting early, swine flu claims 11 more kids in US WASHINGTON — As the swine flu outbreak strikes the U.S. early and hard, health officials note a worrisome number of child deaths and warn that supplies of vaccine will remain scarce for at least the next couple of weeks. After salmonella scare, peanut butter sales hit the roof as consumers seek cost friendly mealsPeanut products doing just fine after health scare WASHINGTON — Go figure: Food makers processed more peanuts over the past year than nearly any other time on record despite a national salmonella outbreak blamed for killing nine people and scaring consumers away from peanut products for months. USDA says Minn. pigs may have tested positive for swine flu, 1st potential cases in US pigsMinn. pigs may have tested positive for swine flu MINNEAPOLIS — Preliminary tests show three pigs in Minnesota may have contracted the swine flu virus making them the first potential U.S. cases in swine, agricultural officials said Friday. They stressed the finding does not threaten food safety. Pfizer on track for speedy pruning, alignment of research programs post Wyeth acquisitionPfizer on track for speedy research alignment TRENTON, N.J. — Megamergers in the pharmaceutical industry usually take many months to sort out, but the two research directors at newly combined Pfizer Inc. and Wyeth say they’re off to a running start. Swine flu hitting especially early, claims 11 more kids; vaccine scarcer than expected for nowSwine flu hits hard, early - claims 11 more kids WASHINGTON — Swine flu is causing unprecedented illness for so early in the fall — including a worrisome count of child deaths — and the government warned Friday that vaccine supplies will be even more scarce than expected through this month. FDA approves Merck’s cervical cancer vaccine Gardasil to prevent genital warts in boysFDA approves Merck’s Gardasil for boys WASHINGTON — Drugmaker Merck said Friday that U.S. regulators cleared its vaccine Gardasil to prevent genital warts in boys, a new use for a product already approved to prevent cervical cancer in women. Gov’t: Swine flu causing unprecedented amount of illnesses; 11 more children died in past weekGov’t: Swine flu linked to 11 more child deaths WASHINGTON — The swine flu is causing an unprecedented amount of illness for this early in the fall, with the deaths of 11 more children reported in the past week. And less vaccine than expected will be ready by month’s end, federal health officials said Friday. |
Latest TweetsProducts And Services
Latest Friend FeedsProducts And Services
|
